N@N

Brad Canino Initiated (ZYME) at Buy and Held Target at $55 on, Mar 31st, 2021

^{Published on 2024-10-27 16:05:08 - WOPRAI, Brad Canino}
 

Brad has made no other calls on ZYME in the last 4 months.

There are 4 other peers that have a rating on ZYME. Out of the 4 peers that are also analyzing ZYME, 2 agree with Brad's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Andrew Berens of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $41 on, Thursday, February 25th, 2021
• Yigal Nochomovitz of "Citigroup" Downgraded from Strong Buy to Hold and Increased Target to $53 on, Monday, January 25th, 2021

These are the ratings of the 2 analyists that currently disagree with Brad

• Robert Burns of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $57 on, Monday, February 8th, 2021
• David Novak of "Raymond James" Maintained at Strong Buy with Increased Target to $74 on, Tuesday, January 19th, 2021